Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Directorate Change

29 Jun 2009 07:00

RNS Number : 6190U
China Real Estate Opportunities PLC
29 June 2009
 



CHINA REAL ESTATE OPPORTUNITIES PLC

Board Changes

China Real Estate Opportunities plc ('"CREO" or the "Company"announces the appointment of Richard Anthony David to the Board. Mr David, aged 46, is Managing Director of Treasury Holdings China Limited and based in Shanghai. He has worked in the real estate industry since 1981 and been based in China since 1999. He joined Treasury Holdings China Limited in August 2007 having previously been Head of China Real Estate for Macquarie Bank Limited of Australia.

The Directors would also like to announce that Mr Robert Tincknell, non-executive Director of the Company, has resigned from the Board to take up a Directorship with Real Estate Opportunities plc ("REO"). Mr Tincknell was previously based in Shanghai and held the position of Managing Director in Treasury Holdings China Limited until early 2008 when he returned to the UK to take up the position of Managing Director of Treasury Holdings UK assuming operational responsibility for the UK activities of REO.

As with all appointments to the board of the Company, Mr David's appointment is subject to consent from the Jersey Regulator. Having regard to the residence of the Directors and the location of the Company's business and assets, The Panel on Takeovers and Mergers has confirmed that, upon Mr David's appointment becoming unconditionalit would no longer regard the Company as one to which the City Code on Takeovers and Mergers would apply.

Ray Horney, Chairman of CREO, commented:

"I would like to thank Rob for his contribution to the Company since its launch and welcome the appointment of Richard to the Board." 

Details of Mr David's directorships in the last five years and current directorships are detailed below:

Past directorships held within the last five years

Past directorships held within the last five years

Anting Investments Limited

Austian (Tianjin) Property Development Co Limited

China Property Investments Limited

First China Property Development Limited

First China Property Group Limited

First China Property Management Limited

Macquarie (Tianjin) Property Services Co. Ltd

Macquarie Hallway Property Limited

Macquarie Jin Lin (Mauritius) Pty Ltd

Macquarie Jin Lin Pty Limited

Macquarie Property China Pty Limited

Macquarie Real Estate Asia Limited

Markgold International Housing and Land Consulting (Beijing) Co Ltd

Markgold International Housing and Land Consulting (Shanghai) Co Ltd

Pasley International Limited

San Ling Investments Limited

Shanghai Anting Waratah Real Estate Development Co, Limited

Shanghai Chengli Properties Co Ltd

Shanghai International Company Limited

Shanghai Pdg Waratah Property Co., Ltd

Tianjin Macquarie Property Development Management Co Limited 

Current directorships

Shanghai Huatian Property Development Co., Ltd 

Shanghai Central Land Property Co., Ltd

Shanghai Vision Honest Real Estate Development Co., Ltd

Beijing Dream Land Industrial Development Co., Ltd

Beijing Treasury Industrial Development Co., Ltd

Qingdao Shangshi CREO Real Estate Co., Ltd 

Qingdao CREO Logistics Park Co., Ltd

Nanjing CREO Investment Consulting Co., Ltd

Treasury (Shanghai) Real Estate Consulting Co., Ltd

Treasury Holdings (Shanghai) Property Management Co., Ltd

Treasury Holdings China Limited Qingdao Rep. Office

Treasury Holdings Real Estate (HK) Ltd

Treasury Holdings Limited

Jagard Pty Ltd

There are no further details required to be disclosed in respect of Mr David's appointment pursuant to schedule 2(g) of the AIM rules. 

 

ENDSContact: CREORay Horney, Chairman Tel: + 44 (0)1273 775225 Sarah Moriarty, Investor Relations  Tel: +353 1 6189455 Matrix Corporate CapitalPaul Fincham Tel +44 (0) 203206 7000 DavyDes Carville Tel: +353 1 679 6363 Bankside ConsultantsSimon Rothschild, Oliver Winters Tel: + 44 (0)207 367 8888

Murray ConsultantsEd Micheau Tel: + 3531 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABUGDLBBDGGCL
Date   Source Headline
28th Jun 202212:33 pmRNSResult of AGM
28th Jun 20227:00 amRNSAGM Statement
27th May 20227:00 amRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSPosting of 2021 Annual Report and Accounts
23rd May 20227:01 amRNSFinal Results
23rd May 20227:00 amRNSCollaboration agreement with Intuitive
18th May 20223:22 pmRNSHolding(s) in Company
17th May 20227:00 amRNSNotice of Results
28th Apr 20227:00 amRNSTrading update and notice of results
20th Apr 20227:00 amRNSOpening of Singapore regional hub
5th Apr 20227:00 amRNSCTO wins Technology Innovator of the Year Award
16th Mar 20227:00 amRNSAlbyn Medical earn out update
28th Feb 20227:00 amRNSTotal Voting Rights
7th Feb 20227:00 amRNSPresentation at Growth and Innovation Forum 2022
4th Feb 20227:00 amRNSAward of Shares under Share Incentive Plan
3rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20224:35 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSTrading update
24th Jan 20227:00 amRNSLicensing & Partnership update
31st Dec 20217:00 amRNSTotal Voting Rights
23rd Dec 20217:00 amRNSExercise of Options
30th Nov 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSExercise of Options
12th Nov 20217:00 amRNSAcquisition of Aber Electronics Limited
11th Nov 20217:00 amRNSAppointment of Joint Broker
30th Sep 202112:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSHalf-year Report
9th Sep 202111:23 amRNSDirector/PDMR Shareholding
8th Sep 20213:59 pmRNSHolding(s) in Company
16th Aug 20213:34 pmRNSOpen Offer Launch, Posting of Circular & GM Notice
13th Aug 20214:45 pmRNSResult of Placing
12th Aug 20215:37 pmRNSProposed Placing & Open Offer, Launch of ABB
30th Jul 20215:00 pmRNSTotal Voting Rights
20th Jul 20213:42 pmRNSShare Awards, Director Dealings & Issue of Equity
16th Jul 20217:00 amRNSOpening of United States East Coast Headquarters
1st Jul 20218:00 amRNSIssue of Equity
30th Jun 202110:30 amRNSResult of AGM
16th Jun 20217:00 amRNSMicroBlate Fine’s first in-human use update
14th Jun 20217:00 amRNSAcquisition of freehold site for £4.25m
4th Jun 20217:01 amRNSNotice of AGM
4th Jun 20217:00 amRNSFinal Results
26th May 20217:00 amRNSFurther health economics data validates technology
19th May 20217:00 amRNSTrading Update
30th Apr 20217:00 amRNSTotal Voting Rights
19th Apr 20217:00 amRNSExercise of Options
19th Feb 202111:31 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSTrading update
7th Jan 20217:00 amRNSUS FDA clearance for MicroBlate™ Flex device
9th Dec 202011:06 amRNSSecond Price Monitoring Extn
9th Dec 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.